<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">30258014</PMID><DateCompleted><Year>2019</Year><Month>08</Month><Day>30</Day></DateCompleted><DateRevised><Year>2023</Year><Month>12</Month><Day>13</Day></DateRevised><Article PubModel="Electronic-Print"><Journal><ISSN IssnType="Electronic">1098-5514</ISSN><JournalIssue CitedMedium="Internet"><Volume>92</Volume><Issue>24</Issue><PubDate><Year>2018</Year><Month>Dec</Month><Day>15</Day></PubDate></JournalIssue><Title>Journal of virology</Title><ISOAbbreviation>J Virol</ISOAbbreviation></Journal><ArticleTitle>CVB3 Nonstructural 2A Protein Modulates SREBP1a Signaling via the MEK/ERK Pathway.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">e01060-18</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1128/JVI.01060-18</ELocationID><Abstract><AbstractText>Coxsackievirus B3 (CVB3) is the predominant pathogen of viral myocarditis. In our previous study, we found that CVB3 caused abnormal lipid accumulation in host cells. However, the underlying mechanisms by which CVB3 disrupts and exploits the host lipid metabolism are not well understood. Sterol regulatory element binding protein 1 (SREBP1) is the major transcriptional factor in lipogenic genes expression. In this study, we demonstrated that CVB3 infection and nonstructural 2A protein upregulated and activated SREBP1a at the transcriptional level. Deletion analysis of SREBP1a promoter revealed that two regions, -1821/-1490 and -312/+217, in this promoter were both required for its activation by 2A. These promoter regions possessed several binding motifs for transcription factor SP1. Next, we used SP1-specific small interfering RNAs (siRNAs) to confirm that SP1 might be the essential factor in SREBP1a upregulation by 2A. Furthermore, we showed that MEK/ERK pathway was involved in the activation of SREBP1a by 2A and that blocking this signaling pathway with the specific inhibitor U0126 attenuated SREBP1a activation and lipid accumulation by 2A. Finally, we showed that inhibition of SREBP1 with siRNAs attenuated lipid accumulation induced by CVB3 infection and reduced virus replication. Moreover, inhibition of the MEK/ERK pathway also led to reduction of SREBP1a activation, lipid accumulation, and virus replication during CVB3 infection. Taken together, these data demonstrate that CVB3 nonstructural 2A protein activates SREBP1a at the transcription level through a mechanism involving MEK/ERK signaling pathway and SP1 transcription factor, which promotes cellular lipid accumulation and benefits virus replication.<b>IMPORTANCE</b> Coxsackievirus B3 (CVB3) infection is the leading cause of viral myocarditis, but effective vaccines and antiviral therapies against CVB3 infection are still lacking. It is important to understand the precise interactions between host and virus for the rational design of effective therapies. During infection, CVB3 disrupts and exploits host lipid metabolism to promote excessive lipid accumulation, which benefits virus replication. SREBP1 is the master regulator of cellular lipid metabolism. Here, we report that one of the viral nonstructural proteins, 2A, upregulates and activates SREBP1a. Furthermore, we find that inhibition of SREBP1 decreases CVB3 virus replication. These results reveal the regulation of SREBP1a expression by 2A and the roles of SREBP1 in lipid accumulation and viral replication during CVB3 infection. Our findings provide a new insight into CVB3 host interactions and inform a potential novel therapeutic target for this important pathogen.</AbstractText><CopyrightInformation>Copyright &#xa9; 2018 American Society for Microbiology.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Lei</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Central Laboratory, Xinqiao Hospital, Army Medical University (Third Military Medical University), Chongqing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xie</LastName><ForeName>Wei</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Central Laboratory, Xinqiao Hospital, Army Medical University (Third Military Medical University), Chongqing, China xiewei@tmmu.edu.cn zhangkebin12@163.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Le</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Central Laboratory, Xinqiao Hospital, Army Medical University (Third Military Medical University), Chongqing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Defeng</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Central Laboratory, Xinqiao Hospital, Army Medical University (Third Military Medical University), Chongqing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yu</LastName><ForeName>Hua</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Central Laboratory, Xinqiao Hospital, Army Medical University (Third Military Medical University), Chongqing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xiong</LastName><ForeName>Junzhi</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Central Laboratory, Xinqiao Hospital, Army Medical University (Third Military Medical University), Chongqing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Peng</LastName><ForeName>Jin</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Central Laboratory, Xinqiao Hospital, Army Medical University (Third Military Medical University), Chongqing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Qiu</LastName><ForeName>Jing</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Central Laboratory, Xinqiao Hospital, Army Medical University (Third Military Medical University), Chongqing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sheng</LastName><ForeName>Halei</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Central Laboratory, Xinqiao Hospital, Army Medical University (Third Military Medical University), Chongqing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>He</LastName><ForeName>Xiaomei</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Central Laboratory, Xinqiao Hospital, Army Medical University (Third Military Medical University), Chongqing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Kebin</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Central Laboratory, Xinqiao Hospital, Army Medical University (Third Military Medical University), Chongqing, China xiewei@tmmu.edu.cn zhangkebin12@163.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>11</Month><Day>27</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Virol</MedlineTA><NlmUniqueID>0113724</NlmUniqueID><ISSNLinking>0022-538X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C497387">SREBF1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016329">Sp1 Transcription Factor</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C108209">SP1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D051780">Sterol Regulatory Element Binding Protein 1</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D017361">Viral Nonstructural Proteins</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D001665" MajorTopicYN="N">Binding Sites</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003384" MajorTopicYN="N">Coxsackievirus Infections</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D029822" MajorTopicYN="N">Enterovirus B, Human</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000472" MajorTopicYN="Y">pathogenicity</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006367" MajorTopicYN="N">HeLa Cells</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D050356" MajorTopicYN="N">Lipid Metabolism</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020935" MajorTopicYN="N">MAP Kinase Signaling System</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011401" MajorTopicYN="N">Promoter Regions, Genetic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016329" MajorTopicYN="N">Sp1 Transcription Factor</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051780" MajorTopicYN="N">Sterol Regulatory Element Binding Protein 1</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015533" MajorTopicYN="N">Transcriptional Activation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015854" MajorTopicYN="N">Up-Regulation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017361" MajorTopicYN="N">Viral Nonstructural Proteins</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014779" MajorTopicYN="N">Virus Replication</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">2A</Keyword><Keyword MajorTopicYN="N">SREBP1a</Keyword><Keyword MajorTopicYN="N">coxsackievirus B3</Keyword><Keyword MajorTopicYN="N">lipid accumulation</Keyword><Keyword MajorTopicYN="N">virus replication</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>6</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>9</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>9</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>8</Month><Day>31</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>9</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2019</Year><Month>5</Month><Day>27</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30258014</ArticleId><ArticleId IdType="pmc">PMC6258932</ArticleId><ArticleId IdType="doi">10.1128/JVI.01060-18</ArticleId><ArticleId IdType="pii">JVI.01060-18</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Garmaroudi FS, Marchant D, Hendry R, Luo H, Yang D, Ye X, Shi J, McManus BM. 2015. Coxsackievirus B3 replication and pathogenesis. Future Microbiol 10:629&#x2013;653. doi:10.2217/fmb.15.5.</Citation><ArticleIdList><ArticleId IdType="doi">10.2217/fmb.15.5</ArticleId><ArticleId IdType="pubmed">25865198</ArticleId></ArticleIdList></Reference><Reference><Citation>Harris KG, Coyne CB. 2014. Death waits for no man&#x2014;does it wait for a virus? How enteroviruses induce and control cell death. Cytokine Growth Factor Rev 25:587&#x2013;596. doi:10.1016/j.cytogfr.2014.08.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cytogfr.2014.08.002</ArticleId><ArticleId IdType="pmc">PMC4371850</ArticleId><ArticleId IdType="pubmed">25172372</ArticleId></ArticleIdList></Reference><Reference><Citation>Shauer A, Gotsman I, Keren A, Zwas DR, Hellman Y, Durst R, Admon D. 2013. Acute viral myocarditis: current concepts in diagnosis and treatment. Isr Med Assoc J 15:180&#x2013;185.</Citation><ArticleIdList><ArticleId IdType="pubmed">23662385</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang L, Parham NJ, Zhang F, Aasa-Chapman M, Gould EA, Zhang H. 2012. Vaccination with coxsackievirus B3 virus-like particles elicits humoral immune response and protects mice against myocarditis. Vaccine 30:2301&#x2013;2308. doi:10.1016/j.vaccine.2012.01.061.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2012.01.061</ArticleId><ArticleId IdType="pubmed">22306858</ArticleId></ArticleIdList></Reference><Reference><Citation>Tam PE. 2006. Coxsackievirus myocarditis: interplay between virus and host in the pathogenesis of heart disease. Viral Immunol 19:133&#x2013;146. doi:10.1089/vim.2006.19.133.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/vim.2006.19.133</ArticleId><ArticleId IdType="pubmed">16817756</ArticleId></ArticleIdList></Reference><Reference><Citation>Lorizate M, Krausslich HG. 2011. Role of lipids in virus replication. Cold Spring Harb Perspect Biol 3:a4820. doi:10.1101/cshperspect.a004820.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/cshperspect.a004820</ArticleId><ArticleId IdType="pmc">PMC3179339</ArticleId><ArticleId IdType="pubmed">21628428</ArticleId></ArticleIdList></Reference><Reference><Citation>Richards AL, Soares-Martins JA, Riddell GT, Jackson WT. 2014. Generation of unique poliovirus RNA replication organelles. mBio 5:e813&#x2013;e833.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3940031</ArticleId><ArticleId IdType="pubmed">24570367</ArticleId></ArticleIdList></Reference><Reference><Citation>Horton JD, Shah NA, Warrington JA, Anderson NN, Park SW, Brown MS, Goldstein JL. 2003. Combined analysis of oligonucleotide microarray data from transgenic and knockout mice identifies direct SREBP target genes. Proc Natl Acad Sci U S A 100:12027&#x2013;12032. doi:10.1073/pnas.1534923100.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1534923100</ArticleId><ArticleId IdType="pmc">PMC218707</ArticleId><ArticleId IdType="pubmed">14512514</ArticleId></ArticleIdList></Reference><Reference><Citation>Waris G, Felmlee DJ, Negro F, Siddiqui A. 2007. Hepatitis C virus induces proteolytic cleavage of sterol regulatory element binding proteins and stimulates their phosphorylation via oxidative stress. J Virol 81:8122&#x2013;8130. doi:10.1128/JVI.00125-07.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00125-07</ArticleId><ArticleId IdType="pmc">PMC1951320</ArticleId><ArticleId IdType="pubmed">17507484</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim KH, Hong SP, Kim K, Park MJ, Kim KJ, Cheong J. 2007. HCV core protein induces hepatic lipid accumulation by activating SREBP1 and PPAR&#x3b3;. Biochem Biophys Res Commun 355:883&#x2013;888. doi:10.1016/j.bbrc.2007.02.044.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2007.02.044</ArticleId><ArticleId IdType="pubmed">17331464</ArticleId></ArticleIdList></Reference><Reference><Citation>Oem JK, Jackel-Cram C, Li YP, Zhou Y, Zhong J, Shimano H, Babiuk LA, Liu Q. 2008. Activation of sterol regulatory element-binding protein 1c and fatty acid synthase transcription by hepatitis C virus nonstructural protein 2. J Gen Virol 89:1225&#x2013;1230. doi:10.1099/vir.0.83491-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/vir.0.83491-0</ArticleId><ArticleId IdType="pubmed">18420801</ArticleId></ArticleIdList></Reference><Reference><Citation>Park CY, Jun HJ, Wakita T, Cheong JH, Hwang SB. 2009. Hepatitis C virus nonstructural 4B protein modulates sterol regulatory element-binding protein signaling via the AKT pathway. J Biol Chem 284:9237&#x2013;9246. doi:10.1074/jbc.M808773200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M808773200</ArticleId><ArticleId IdType="pmc">PMC2666576</ArticleId><ArticleId IdType="pubmed">19204002</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu Y, Maguire TG, Alwine JC. 2012. Human cytomegalovirus infection induces adipocyte-like lipogenesis through activation of sterol regulatory element binding protein 1. J Virol 86:2942&#x2013;2949. doi:10.1128/JVI.06467-11.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.06467-11</ArticleId><ArticleId IdType="pmc">PMC3302344</ArticleId><ArticleId IdType="pubmed">22258239</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu Y, Pierciey FJ, Maguire TG, Alwine JC. 2013. PKR-like endoplasmic reticulum kinase is necessary for lipogenic activation during HCMV infection. PLoS Pathog 9:e1003266. doi:10.1371/journal.ppat.1003266.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1003266</ArticleId><ArticleId IdType="pmc">PMC3617203</ArticleId><ArticleId IdType="pubmed">23592989</ArticleId></ArticleIdList></Reference><Reference><Citation>Petersen J, Drake MJ, Bruce EA, Riblett AM, Didigu CA, Wilen CB, Malani N, Male F, Lee FH, Bushman FD, Cherry S, Doms RW, Bates P, Briley KJ. 2014. The major cellular sterol regulatory pathway is required for Andes virus infection. PLoS Pathog 10:e1003911. doi:10.1371/journal.ppat.1003911.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1003911</ArticleId><ArticleId IdType="pmc">PMC3916400</ArticleId><ArticleId IdType="pubmed">24516383</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie W, Wang L, Dai Q, Yu H, He X, Xiong J, Sheng H, Zhang D, Xin R, Qi Y, Hu F, Guo S, Zhang K. 2015. Activation of AMPK restricts coxsackievirus B3 replication by inhibiting lipid accumulation. J Mol Cell Cardiol 85:155&#x2013;167. doi:10.1016/j.yjmcc.2015.05.021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.yjmcc.2015.05.021</ArticleId><ArticleId IdType="pubmed">26055448</ArticleId></ArticleIdList></Reference><Reference><Citation>Horton JD, Goldstein JL, Brown MS. 2002. SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver. J Clin Invest 109:1125&#x2013;1131. doi:10.1172/JCI0215593.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI0215593</ArticleId><ArticleId IdType="pmc">PMC150968</ArticleId><ArticleId IdType="pubmed">11994399</ArticleId></ArticleIdList></Reference><Reference><Citation>Porstmann T, Griffiths B, Chung YL, Delpuech O, Griffiths JR, Downward J, Schulze A. 2005. PKB/Akt induces transcription of enzymes involved in cholesterol and fatty acid biosynthesis via activation of SREBP. Oncogene 24:6465&#x2013;6481. doi:10.1038/sj.onc.1208802.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sj.onc.1208802</ArticleId><ArticleId IdType="pubmed">16007182</ArticleId></ArticleIdList></Reference><Reference><Citation>Du X, Kristiana I, Wong J, Brown AJ. 2006. Involvement of Akt in ER-to-Golgi transport of SCAP/SREBP: a link between a key cell proliferative pathway and membrane synthesis. Mol Biol Cell 17:2735&#x2013;2745. doi:10.1091/mbc.e05-11-1094.</Citation><ArticleIdList><ArticleId IdType="doi">10.1091/mbc.e05-11-1094</ArticleId><ArticleId IdType="pmc">PMC1474807</ArticleId><ArticleId IdType="pubmed">16571675</ArticleId></ArticleIdList></Reference><Reference><Citation>Roth G, Kotzka J, Kremer L, Lehr S, Lohaus C, Meyer HE, Krone W, Muller-Wieland D. 2000. MAP kinases Erk1/2 phosphorylate sterol regulatory element-binding protein (SREBP)-1a at serine 117 in vitro. J Biol Chem 275:33302&#x2013;33307. doi:10.1074/jbc.M005425200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M005425200</ArticleId><ArticleId IdType="pubmed">10915800</ArticleId></ArticleIdList></Reference><Reference><Citation>Shao W, Espenshade PJ. 2012. Expanding roles for SREBP in metabolism. Cell Metab 16:414&#x2013;419. doi:10.1016/j.cmet.2012.09.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmet.2012.09.002</ArticleId><ArticleId IdType="pmc">PMC3466394</ArticleId><ArticleId IdType="pubmed">23000402</ArticleId></ArticleIdList></Reference><Reference><Citation>Damiano F, Alemanno S, Gnoni GV, Siculella L. 2010. Translational control of the sterol-regulatory transcription factor SREBP-1 mRNA in response to serum starvation or ER stress is mediated by an internal ribosome entry site. Biochem J 429:603&#x2013;612. doi:10.1042/BJ20091827.</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/BJ20091827</ArticleId><ArticleId IdType="pubmed">20513236</ArticleId></ArticleIdList></Reference><Reference><Citation>Fernandez-Alvarez A, Tur G, Lopez-Rodas G, Casado M. 2008. Reciprocal regulation of the human sterol regulatory element binding protein (SREBP)-1a promoter by Sp1 and EGR-1 transcription factors. FEBS Lett 582:177&#x2013;184. doi:10.1016/j.febslet.2007.11.083.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.febslet.2007.11.083</ArticleId><ArticleId IdType="pubmed">18068676</ArticleId></ArticleIdList></Reference><Reference><Citation>Esfandiarei M, McManus BM. 2008. Molecular biology and pathogenesis of viral myocarditis. Annu Rev Pathol 3:127&#x2013;155. doi:10.1146/annurev.pathmechdis.3.121806.151534.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev.pathmechdis.3.121806.151534</ArticleId><ArticleId IdType="pubmed">18039131</ArticleId></ArticleIdList></Reference><Reference><Citation>Laitinen OH, Svedin E, Kapell S, Hankaniemi MM, Larsson PG, Domsgen E, Stone VM, Maatta J, Hyoty H, Hytonen VP, Flodstrom-Tullberg M. 2018. New coxsackievirus 2A(pro) and 3C(pro) protease antibodies for virus detection and discovery of pathogenic mechanisms. J Virol Methods 255:29&#x2013;37. doi:10.1016/j.jviromet.2018.02.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jviromet.2018.02.001</ArticleId><ArticleId IdType="pubmed">29425680</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang Y, Wang J, Lu X, Thewke DP, Mason RJ. 2005. KGF induces lipogenic genes through a PI3K and JNK/SREBP-1 pathway in H292 cells. J Lipid Res 46:2624&#x2013;2635. doi:10.1194/jlr.M500154-JLR200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1194/jlr.M500154-JLR200</ArticleId><ArticleId IdType="pubmed">16162944</ArticleId></ArticleIdList></Reference><Reference><Citation>Makdissy N, Haddad K, Mouawad C, Popa I, Younsi M, Valet P, Brunaud L, Ziegler O, Quilliot D. 2015. Regulation of SREBPs by sphingomyelin in adipocytes via a caveolin and Ras-ERK-MAPK-CREB signaling pathway. PLoS One 10:e133181. doi:10.1371/journal.pone.0133181.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0133181</ArticleId><ArticleId IdType="pmc">PMC4521865</ArticleId><ArticleId IdType="pubmed">26230734</ArticleId></ArticleIdList></Reference><Reference><Citation>Akil A, Wedeh G, Zahid MM, Gassama-Diagne A. 2016. SUMO1 depletion prevents lipid droplet accumulation and HCV replication. Arch Virol 161:141&#x2013;148. doi:10.1007/s00705-015-2628-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00705-015-2628-3</ArticleId><ArticleId IdType="pubmed">26449956</ArticleId></ArticleIdList></Reference><Reference><Citation>Spencer CM, Schafer XL, Moorman NJ, Munger J. 2011. Human cytomegalovirus induces the activity and expression of acetyl-coenzyme A carboxylase, a fatty acid biosynthetic enzyme whose inhibition attenuates viral replication. J Virol 85:5814&#x2013;5824. doi:10.1128/JVI.02630-10.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.02630-10</ArticleId><ArticleId IdType="pmc">PMC3126312</ArticleId><ArticleId IdType="pubmed">21471234</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee WA, Martin JC. 2006. Perspectives on the development of acyclic nucleotide analogs as antiviral drugs. Antiviral Res 71:254&#x2013;259. doi:10.1016/j.antiviral.2006.05.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.antiviral.2006.05.020</ArticleId><ArticleId IdType="pubmed">16837073</ArticleId></ArticleIdList></Reference><Reference><Citation>Andrei G, De Clercq E, Snoeck R. 2008. Novel inhibitors of human CMV. Curr Opin Investig Drugs 9:132&#x2013;145.</Citation><ArticleIdList><ArticleId IdType="pubmed">18246516</ArticleId></ArticleIdList></Reference><Reference><Citation>Kivela AM, Dijkstra MH, Heinonen SE, Gurzeler E, Jauhiainen S, Levonen AL, Yla-Herttuala S. 2012. Regulation of endothelial lipase and systemic HDL cholesterol levels by SREBPs and VEGF-A. Atherosclerosis 225:335&#x2013;340. doi:10.1016/j.atherosclerosis.2012.09.039.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.atherosclerosis.2012.09.039</ArticleId><ArticleId IdType="pubmed">23102786</ArticleId></ArticleIdList></Reference><Reference><Citation>Kotzka J, Muller-Wieland D, Roth G, Kremer L, Munck M, Schurmann S, Knebel B, Krone W. 2000. Sterol regulatory element binding proteins (SREBP)-1a and SREBP-2 are linked to the MAP kinase cascade. J Lipid Res 41:99&#x2013;108.</Citation><ArticleIdList><ArticleId IdType="pubmed">10627507</ArticleId></ArticleIdList></Reference><Reference><Citation>Na TY, Shin YK, Roh KJ, Kang SA, Hong I, Oh SJ, Seong JK, Park CK, Choi YL, Lee MO. 2009. Liver X receptor mediates hepatitis B virus X protein-induced lipogenesis in hepatitis B virus-associated hepatocellular carcinoma. Hepatology 49:1122&#x2013;1131. doi:10.1002/hep.22740.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/hep.22740</ArticleId><ArticleId IdType="pubmed">19105208</ArticleId></ArticleIdList></Reference><Reference><Citation>Moriishi K, Mochizuki R, Moriya K, Miyamoto H, Mori Y, Abe T, Murata S, Tanaka K, Miyamura T, Suzuki T, Koike K, Matsuura Y. 2007. Critical role of PA28&#x3b3; in hepatitis C virus-associated steatogenesis and hepatocarcinogenesis. Proc Natl Acad Sci U S A 104:1661&#x2013;1666. doi:10.1073/pnas.0607312104.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0607312104</ArticleId><ArticleId IdType="pmc">PMC1776165</ArticleId><ArticleId IdType="pubmed">17234812</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Q, Qiao L, Yang J, Zhou Y, Liu Q. 2015. Stronger activation of SREBP-1a by nucleus-localized HBx. Biochem Biophys Res Commun 460:561&#x2013;565. doi:10.1016/j.bbrc.2015.03.069.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2015.03.069</ArticleId><ArticleId IdType="pubmed">25800871</ArticleId></ArticleIdList></Reference><Reference><Citation>Qiao L, Wu Q, Lu X, Zhou Y, Fernandez-Alvarez A, Ye L, Zhang X, Han J, Casado M, Liu Q. 2013. SREBP-1a activation by HBx and the effect on hepatitis B virus enhancer II/core promoter. Biochem Biophys Res Commun 432:643&#x2013;649. doi:10.1016/j.bbrc.2013.02.030.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2013.02.030</ArticleId><ArticleId IdType="pubmed">23422505</ArticleId></ArticleIdList></Reference><Reference><Citation>Krycer JR, Sharpe LJ, Luu W, Brown AJ. 2010. The Akt-SREBP nexus: cell signaling meets lipid metabolism. Trends Endocrinol Metab 21:268&#x2013;276. doi:10.1016/j.tem.2010.01.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tem.2010.01.001</ArticleId><ArticleId IdType="pubmed">20117946</ArticleId></ArticleIdList></Reference><Reference><Citation>Luo H, Yanagawa B, Zhang J, Luo Z, Zhang M, Esfandiarei M, Carthy C, Wilson JE, Yang D, McManus BM. 2002. Coxsackievirus B3 replication is reduced by inhibition of the extracellular signal-regulated kinase (ERK) signaling pathway. J Virol 76:3365&#x2013;3373. doi:10.1128/JVI.76.7.3365-3373.2002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.76.7.3365-3373.2002</ArticleId><ArticleId IdType="pmc">PMC136021</ArticleId><ArticleId IdType="pubmed">11884562</ArticleId></ArticleIdList></Reference><Reference><Citation>Xin L, Ma X, Xiao Z, Yao H, Liu Z. 2015. Coxsackievirus B3 induces autophagy in HeLa cells via the AMPK/MEK/ERK and Ras/Raf/MEK/ERK signaling pathways. Infect Genet Evol 36:46&#x2013;54. doi:10.1016/j.meegid.2015.08.026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.meegid.2015.08.026</ArticleId><ArticleId IdType="pubmed">26305625</ArticleId></ArticleIdList></Reference><Reference><Citation>Bose SK, Kim H, Meyer K, Wolins N, Davidson NO, Ray R. 2014. Forkhead box transcription factor regulation and lipid accumulation by hepatitis C virus. J Virol 88:4195&#x2013;4203. doi:10.1128/JVI.03327-13.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.03327-13</ArticleId><ArticleId IdType="pmc">PMC3993747</ArticleId><ArticleId IdType="pubmed">24478438</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheung W, Gill M, Esposito A, Kaminski CF, Courousse N, Chwetzoff S, Trugnan G, Keshavan N, Lever A, Desselberger U. 2010. Rotaviruses associate with cellular lipid droplet components to replicate in viroplasms, and compounds disrupting or blocking lipid droplets inhibit viroplasm formation and viral replication. J Virol 84:6782&#x2013;6798. doi:10.1128/JVI.01757-09.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01757-09</ArticleId><ArticleId IdType="pmc">PMC2903253</ArticleId><ArticleId IdType="pubmed">20335253</ArticleId></ArticleIdList></Reference><Reference><Citation>Martin-Acebes MA, Blazquez AB, Jimenez DON, Escribano-Romero E, Saiz JC. 2011. West Nile virus replication requires fatty acid synthesis but is independent on phosphatidylinositol-4-phosphate lipids. PLoS One 6:e24970. doi:10.1371/journal.pone.0024970.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0024970</ArticleId><ArticleId IdType="pmc">PMC3176790</ArticleId><ArticleId IdType="pubmed">21949814</ArticleId></ArticleIdList></Reference><Reference><Citation>Harak C, Lohmann V. 2015. Ultrastructure of the replication sites of positive-strand RNA viruses. Virology 479-480:418&#x2013;433. doi:10.1016/j.virol.2015.02.029.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virol.2015.02.029</ArticleId><ArticleId IdType="pmc">PMC7111692</ArticleId><ArticleId IdType="pubmed">25746936</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang K, Yu H, Xie W, Xu Z, Zhou S, Huang C, Sheng H, He X, Xiong J, Qian G. 2013. Expression of coxsackievirus and adenovirus receptor (CAR)-Fc fusion protein in Pichia pastoris and characterization of its anti-coxsackievirus activity. J Biotechnol 164:461&#x2013;468. doi:10.1016/j.jbiotec.2013.01.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbiotec.2013.01.015</ArticleId><ArticleId IdType="pubmed">23376619</ArticleId></ArticleIdList></Reference><Reference><Citation>Rassmann A, Martin U, Saluz HP, Peter S, Munder T, Henke A. 2013. Identification of gene expression profiles in HeLa cells and HepG2 cells infected with coxsackievirus B3. J Virol Methods 187:190&#x2013;194. doi:10.1016/j.jviromet.2012.08.025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jviromet.2012.08.025</ArticleId><ArticleId IdType="pubmed">23000448</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>